Eric Zhang
Chief Executive Officer at AKSO Biopharmaceutical, Inc.
Net worth: 174 010 $ as of 2023-12-30
Profile
Eric Zhang is the founder of AKSO Biopharmaceutical, Inc. Prior to founding AKSO Biopharmaceutical, he worked as a Director at Versartis, Inc. He also worked as a Director at Aravive Biologics, Inc. from 2016 to 2018.
From 2018 to 2023, he served as an Independent Director at Aravive, Inc. Mr. Zhang received his undergraduate degree from Queen's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARAVIVE, INC.
1.91% | 2023-08-02 | 1,403,303 ( 1.91% ) | 174 010 $ | 2023-12-30 |
Eric Zhang active positions
| Companies | Position | Start |
|---|---|---|
| AKSO Biopharmaceutical, Inc. | Chief Executive Officer | - |
Former positions of Eric Zhang
| Companies | Position | End |
|---|---|---|
| ARAVIVE, INC. | Director/Board Member | 2023-10-01 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Director/Board Member | 2018-09-30 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Director/Board Member | - |
Training of Eric Zhang
| Queen's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
- Stock Market
- Insiders
- Eric Zhang
